Navigation Links
Champions Oncology Names Angela Davies, M.D., Chief Medical Officer
Date:1/6/2014

HACKENSACK, N.J., Jan. 6, 2014 /PRNewswire/ -- Champions Oncology (OTC: CSBR), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the appointment of Angela Davies, M.D., as Chief Medical Officer.

Dr. Davies has demonstrated leadership and success in both academic clinical practice and as an executive in the pharmaceutical industry. Previously, she was Chief Medical Officer of OSI Pharmaceuticals where she led the clinical development program for Tarceva® (erlotinib), as well as other pipeline products, until the company's acquisition by Astellas Pharma. Earlier in her career she was an Associate Professor of Medicine at the University of California, Davis, where she practiced as a medical oncologist and was a principal investigator on NCI sponsored and investigator initiated clinical trials, specializing in thoracic malignancies and development therapeutics.

"Dr. Davies' blend of expertise will enable Champions Oncology to strengthen our relationships with pharmaceutical companies looking to improve drug discovery efforts as well as practicing oncologists seeking new treatment options for patients," said Ronnie Morris, M.D., President of Champions Oncology. "Her unique perspective is a great asset to Champions Oncology and we are pleased to have her join the team."

"As a practicing oncologist, I saw many patients with limited treatment options and highly aggressive cancers that left little time to test therapies," added Dr. Davies. "The ability to evaluate potential treatments with no risk to the patient and in a model highly correlative to the patient's own tumor would have been a great tool for my practice. I look forward to advancing this technology to enable oncologists, patients and drug developers, to benefit from this approach."  '/>"/>

SOURCE Champions Oncology
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
2. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
3. Novation Champions Reusable Packaging for Sustainability in Healthcare
4. Champions Oncology Reports Financial Results for the Quarter Ended July 31, 2012
5. Champions Oncology to Present at Rodman & Renshaw Conference
6. Champions Oncology Reports Resignation Of Director
7. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
8. Sutro Biopharma Closes $26 Million Financing, Expands Development of Novel Immuno-Oncology Products
9. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
10. FLAG Therapeutics and Duquesne University Announce Exclusive Worldwide Licensing Agreement for Novel, Dual-action Targeted Oncology Compounds
11. Eisai Oncology to Present New Research on Eribulin and NEPA at 36th Annual San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Today the U.S. Food ... Bexsero® for the prevention of serogroup B meningococcal ... and Pfizer,s vaccine Trumenba®, which received FDA approval in ... this devastating disease. "I have heard ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... Jan. 23, 2015 More than a third of reproductive-aged ... those with private insurance, filled a prescription for an opioid ... in this week,s Morbidity and Mortality Weekly Report (MMWR). ... to treat moderate to severe pain.  They are also found ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... risk of breast cancer recurrence , , ... taking tamoxifen with certain antidepressants more than doubled the ... medications. The antidepressants inhibit an enzyme, CYP2D6, which helps ... ) , , The study was conducted ...
... of Clinical Oncology Annual MeetingAbstracts: 5033, 3560ORLANDO, Fla., ... Phase I and II trials of BAY 73-4506, ... in multiple tumor types. These data were ... American Society of Clinical Oncology (ASCO)."Bayer is committed ...
Cached Medicine Technology:New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506 2Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506 3
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ has ... (PPHA). The PPHA's passion for others' well-being and shared ... treated for obstructive sleep apnea (OSA) has propelled them into ... the valley. The most recent plans for an event will ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... Nanotechnology is the use of particles which are very ... pose a health hazard. // The petition was raised ... Administration (FDA) to strengthen its regulation of sunscreens that ... are thought to cause inflammatory and immune responses in ...
... the situation in case of an outbreak of bird flu ... preparation.// They are asked to appoint a bird flu tsar. ... have to look harder at immediate practical measures and implement ... ,He said that their problem is that the decision-making was ...
... outlined programs to ease bureaucratic procedures in the department. // ... by the minister in Launceston this morning to 200 of ... is to reduce the number of approvals needed for day-to-day ... within the bureaucratic process and we're addressing those,’ she said. ...
... has been found that cardiovascular clinical trials published between ... whether they were funded by for-profit //organizations or by ... the May 17 issue of JAMA. ,Surveys ... awareness in the medical community that trials funded by ...
... not yet ascertained the top floors of the Melbourne office ... identify the cause of illnesses.// ,Tests on radiofrequency ... establish any link as yet to the seven cases of ... ,Five of these seven cases were employees who had worked ...
... is associated with the formation of blood clots during long ... is thought to be, reveals a new study. ,The ... people, while sitting in cramped places, that cause a reduction ... the formation of clots. This is perhaps the reason why ...
Cached Medicine News:Health News:Results of Clinical Trials Vary According to Source of Funding 2
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Portless Sheath Introducers...
Introducer Sheath Designed for Vascular Access...
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
Medicine Products: